Pallas Capital Advisors LLC

Position in NVS — Novartis AG

CIK 1862282 BRAINTREE, MA

Position in NVS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$283,819

+$57,138 QoQ

Shares Held

1,811

+22.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,163

of 1,603 holders

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 53% Shared 0% None 47%

Healthcare · as of Jun 30, 2026

Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. NVS ranks #10 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	75,730	$19,233,148
2	LLY	ELI LILLY & Co	9,795	$11,748,417
3	MRK	Merck & Co., Inc.	62,572	$8,040,502
4	ABBV	AbbVie Inc.	26,085	$6,564,029
5	BMY	Bristol Myers Squibb Co	77,353	$4,457,079
6	BIIB	Biogen Inc.	12,859	$2,778,315
7	PFE	Pfizer Inc	75,558	$1,819,436
8	AMGN	Amgen Inc	4,792	$1,735,279

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$283,819	1,811	+22.0%	Shares	Sole	2026-08-07
2026-03-31	$226,681	1,484	-17.6%	Shares	Sole	2026-04-21
2025-12-31	$248,303	1,801	+1.0%	Shares	Sole	2026-01-14
2025-09-30	$228,651	1,783	0.0%	Shares	Sole	2025-11-07
2025-06-30	$215,760	1,783	-68.1%	Shares	Sole	2025-07-09
2023-12-31	$565,028	5,596	+148.8%	Shares	Sole	2024-01-22
2023-03-31	$206,908	2,249	-30.6%	Shares	Sole	2023-05-02
2022-12-31	$294,023	3,241	+5.7%	Shares	Sole	2023-01-24
2022-09-30	$232,970	3,065	+0.3%	Shares	Sole	2022-11-07
2022-06-30	$258,239	3,055	-6.7%	Shares	Sole	2022-08-11
2022-03-31	$287,293	3,274	-30.3%	Shares	Sole	2022-04-20
2021-12-31	$410,934	4,698	-30.2%	Shares	Sole	2022-02-01
2021-09-30	$550,215	6,728	+35.4%	Shares	Sole	2021-11-12
2021-06-30	$453,371	4,969	+15.0%	Shares	Sole	2021-08-11
2021-03-31	$369,188	4,319	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.